Yüklüyor......
Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer
PURPOSE OF REVIEW: To delineate how recent findings on prostate-specific antigen (PSA) can improve prediction of risk, detection, and prediction of clinical endpoints of prostate cancer (PCa). RECENT FINDINGS: The widely used PSA cut-point of 4.0 ng/ml increasingly appears arbitrary, but no cut-poin...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2782618/ https://ncbi.nlm.nih.gov/pubmed/19318948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOU.0b013e32832a2d10 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|